Новости Geistlich Pharma AG

PD Dr. med. dent. Nadja Nänni is responsible for one of the highlights of "Geistlich + YOU3": the virtual workshop. She tells us what she is most looking forward to and what workshop participants can expect from Geistlich vLab^TM.

PD Dr. med. dent. Nadja Nänni is responsible for one of the highlights of "Geistlich + YOU3": the virtual workshop. She tells us what she is most looking forward to and what workshop participants can expect from Geistlich vLab^TM.

Do you respond to interactive lectures by renowned speakers? Do you prefer a virtual live hands-on workshop? We offer you both from one source and a whole firework of regeneration in the versatile congress package.

Prof. Dr. Frauke Müller pushes the door to geriatric dentistry wide open. She introduces listeners to her fascinating and multifaceted field, which has many special features compared to general dentistry. The specialist from the University of Geneva is a guest on the new Geistlich Audio Podcast.

Let's look back: The "Geistlich Charity Walk & Run" moved the hearts of 352 employees. In September 2021, they ran and walked the race, covering a total of 4,191 kilometers. This resulted in a donation of 20,955 US dollars, which has now reached its destination.

Let's look back: The "Geistlich Charity Walk & Run" moved the hearts of 352 employees. In September 2021, they ran and walked the race, covering a total of 4,191 kilometers. This resulted in a donation of 20,955 US dollars, which has now reached its destination.

Since 26 May 2021, the new and stricter legislation for the market authorization of medical devices in the EU, the Medical Device Regulation (MDR), has been in force. Geistlich Pharma obtained the first MDR certificates in August 2021, both for the quality management system and for the first product...

In the festive setting of the event organised by the Chamber of Industry and Commerce of Central Switzerland (ihz), Geistlich CEO Ralf P. Halbach and his team accept the Innovation Recognition Award for Geistlich Derma-Gide^®.

Geistlich Pharma has been working successfully with Meta, the medical technology division of C.G.M. S.p.A., for many years. With the acquisition of Meta Technologies S.r.l., Geistlich Pharma is expanding its existing offering as a regeneration specialist by adding a further recognized brand. Meta...

Geistlich Pharma obtains 510(k) clearance from the US Food and Drug Administration (FDA) for its latest product Geistlich Nexo-Gide^®. It will be presented at surgical podiatry and orthopaedic congresses in Florida and Nevada from November 2021. For patients with severe tendon and ligament injuries,...